Skip to main content

ABBOTT LABORATORIES

For the period ended Dec 31, 2025. Filed Feb 20, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Feb 20, 2026

ABT$109.93-3.2%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Table of Contents

Page
PART I.
Item 1.Business1
Item 1A.Risk Factors9
Item 1B.Unresolved Staff Comments15
Item 1C.Cybersecurity15
Item 2.Properties17
Item 3.Legal Proceedings18
Item 4.Mine Safety Disclosures18
PART II.
Item 5.Market for Registrant’s Common Equity, Related Stockholder Matters and Issuer Purchases of Equity Securities21
Item 6.[Reserved]21
Item 7.Management’s Discussion and Analysis of Financial Condition and Results of Operations22
Item 7A.Quantitative and Qualitative Disclosures About Market Risk38
Item 8.Consolidated Financial Statements and Supplementary Data40
Item 9.Changes in and Disagreements with Accountants on Accounting and Financial Disclosure81
Item 9A.Controls and Procedures81
Item 9B.Other Information81
Item 9C.Disclosure Regarding Foreign Jurisdictions that Prevent Inspections81
PART III.
Item 10.Directors, Executive Officers and Corporate Governance82
Item 11.Executive Compensation82
Item 12.Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matters82
Item 13.Certain Relationships and Related Transactions, and Director Independence82
Item 14.Principal Accountant Fees and Services82
PART IV.
Item 15.Exhibit and Financial Statement Schedules83
Signatures90
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.